Published: 3 October 2014
Author(s): Inna Tzoran, Benjamin Brenner, Gleb Sakharov, Javier Trujillo-Santos, Alicia Lorenzo, Olga Madridano, Juan Bosco López-Sáez, Manuel Monreal, RIETE investigators
Section: Original Article

Patients with arterial disease receiving antiplatelet agents may develop venous thromboembolism (VTE) and need anticoagulant therapy, although concomitant use of these drugs may increase bleeding risk. We analyzed RIETE data and compared clinical outcomes depending on decision to discontinue or maintain antiplatelet therapy at VTE diagnosis.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.